Literature DB >> 16175604

Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.

Naoya Kato1, Guijin Ji, Yue Wang, Masanori Baba, Yujin Hoshida, Motoyuki Otsuka, Hiroyoshi Taniguchi, Masaru Moriyama, Narayan Dharel, Tadashi Goto, Run-Xuan Shao, Tadashi Matsuura, Keisuke Ishii, Shuichiro Shiina, Takao Kawabe, Masaaki Muramatsu, Masao Omata.   

Abstract

Hepatitis C virus (HCV) infection is a major risk factor for developing hepatocellular carcinoma (HCC). The host genetic factors that are involved in the development of HCC in patients with HCV infection remain to be investigated. To search for single nucleotide polymorphisms (SNPs) in HCC susceptibility genes, 393 SNPs in 171 candidate genes were examined in 188 Japanese patients with chronic HCV infection, including 77 patients with HCC. HCC-related SNPs were then examined in another 188 patients (including 93 patients with HCC) with chronic HCV infection. Haplotype analyses of HCC-related genes were performed in a total of 376 patients. Of the 393 SNPs, 31 SNPs in 29 genes were significantly associated with HCC based on an initial screening (P < .05). Of these 31 SNPs, 3 SNPs of 3 genes (SCYB14, GFRA1, and CRHR2) were significantly associated with HCC in a secondary screening. Haplotype analyses of these 3 genes identified 2 haplotype blocks associated with HCC. In conclusion, these SNPs and haplotypes located in the SCBY14, CRHR2, and GFRA1 genes will be used as markers to identify a subgroup of Japanese patients with chronic HCV infection who are at high risk of developing HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175604     DOI: 10.1002/hep.20860

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

Review 1.  MICA SNPs and the NKG2D system in virus-induced HCC.

Authors:  Kaku Goto; Naoya Kato
Journal:  J Gastroenterol       Date:  2014-10-01       Impact factor: 7.527

2.  An intronic polymorphism rs2237062 in the CXCL14 gene influences HBV-related HCC progression in Chinese population.

Authors:  Xing Gu; Hao Wang; Aihua Wang; Tonghai Dou; Peng Qi; Qiang Ji; Hui Li; Chunfang Gao
Journal:  Mol Biol Rep       Date:  2011-05-10       Impact factor: 2.316

Review 3.  Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.

Authors:  Matthew M Yeh; Raymond S Yeung; Smith Apisarnthanarax; Renuka Bhattacharya; Carlos Cuevas; William P Harris; Tony Lim Kiat Hon; Siddharth A Padia; James O Park; Kevin M Riggle; Sayed S Daoud
Journal:  World J Hepatol       Date:  2015-06-18

Review 4.  Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.

Authors:  Augusto Villanueva; Beatriz Minguez; Alejandro Forner; Maria Reig; Josep M Llovet
Journal:  Annu Rev Med       Date:  2010       Impact factor: 13.739

5.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12

6.  Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.

Authors:  Zhangyong Hu; Zhipeng Zhou; Guolian Xiong; Yali Wang; Yi Lai; Lan Deng; Jinliang Yang
Journal:  Tumour Biol       Date:  2014-02-26

7.  Association between MDM2-SNP309 and hepatocellular carcinoma in Taiwanese population.

Authors:  Jyh-Der Leu; I-Feng Lin; Ying-Fang Sun; Su-Mei Chen; Chih-Chao Liu; Yi-Jang Lee
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  An intronic polymorphism in the corticotropin-releasing hormone receptor 2 gene increases susceptibility to HBV-related hepatocellular carcinoma in Chinese population.

Authors:  Xing Gu; Peng Qi; Feiguo Zhou; Qiang Ji; Hao Wang; Tonghai Dou; Yunpeng Zhao; Chunfang Gao
Journal:  Hum Genet       Date:  2009-10-08       Impact factor: 4.132

9.  Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.

Authors:  Masaya Sato; Mayuko Kondo; Ryosuke Tateishi; Naoto Fujiwara; Naoya Kato; Haruhiko Yoshida; Masataka Taguri; Kazuhiko Koike
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

10.  Interleukin 18 promoter variants (-137G>C and -607C>A) in patients with chronic hepatitis C: association with treatment response.

Authors:  Stephan L Haas; Christel Weiss; Peter Bugert; Jutta Gundt; Heiko Witt; Manfred V Singer; Thomas Berg; Ulrich Böcker
Journal:  J Clin Immunol       Date:  2009-05-20       Impact factor: 8.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.